Abstract
Purpose In musculoskeletal rehabilitation, blood flow restriction – low load strength training (BFR-LLST) is theoretically indicated – as opposed to traditional heavy strength training – in patients who can or may not heavily load tissues healing from recent surgery. The main purpose was to examine the feasibility of BFR-LLST added to usual care exercise early after cartilage or meniscus repair in the knee joint.
Methods We included 42 patients with cartilage (n=21) or meniscus repair (n=21) in the knee joint. They attended 9 weeks of BFR-LLST added to a usual care exercise at an outpatient rehabilitation center. Outcome measures were assessed at different time points from 4 (baseline) to 26 weeks postoperatively. They included: Adherence, harms, knee joint and thigh pain, perceived exertion, thigh circumference (muscle size proxy), isometric knee-extension strength, self-reported disability and quality of life.
Results On average, patients with cartilage and meniscus repair performed >84 % of the total BFR-LLST supervised sessions. Thirty-eight patients reported 146 adverse events (e.g., dizziness) - none considered serious. A decrease in thigh circumference of the operated leg was not found in both groups from baseline to the end of the intervention period with no exacerbation of knee joint or quadriceps muscle pain.
Conclusions BFR-LLST added to usual care exercise initiated early after cartilage or meniscus repair seems feasible and may prevent disuse thigh muscle atrophy during a period of weight bearing restrictions. Harms were reported, but no serious adverse events were found. Our findings are promising but need replication using RCT-design.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Clinical.Trials.gov (NCT03371901)
Funding Statement
This study was supported by a grant from Praksisfonden (grant number R65-A1601).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Committees on Biomedical Research Ethics for the Capital Region of Denmark approved the study (Protocol nr. 17010473)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Thomas Linding Jakobsen, tlj26{at}hotmail.com Kristian Thorborg, kristian.thorborg{at}regionh.dk Jakob Fisker, jakob.fisker{at}hotmail.com Thomas Kallemose, thomas.kallemose{at}regionh.dk Thomas Bandholm, thomas.quaade.bandholm{at}regionh.dk
Data Availability
All data produced in the present study are available upon reasonable request to the authors
